These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 6363544

  • 21. Stimulation by granulocyte-macrophage colony-stimulating factor of Leishmania tropica killing by macrophages.
    Handman E, Burgess AW.
    J Immunol; 1979 Mar; 122(3):1134-7. PubMed ID: 312818
    [Abstract] [Full Text] [Related]

  • 22. Cell contact-mediated macrophage activation for antileishmanial defense. I. Lymphocyte effector mechanism that is contact dependent and noncytotoxic.
    Panosian CB, Sypek JP, Wyler DJ.
    J Immunol; 1984 Dec; 133(6):3358-65. PubMed ID: 6208278
    [Abstract] [Full Text] [Related]

  • 23. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
    Reiner NE.
    J Immunol; 1987 Mar 15; 138(6):1919-25. PubMed ID: 3493291
    [Abstract] [Full Text] [Related]

  • 24. Macrophage activation for antileishmanial defense by an apparently novel mechanism.
    Wyler DJ, Beller DI, Sypek JP.
    J Immunol; 1987 Feb 15; 138(4):1246-9. PubMed ID: 3100630
    [Abstract] [Full Text] [Related]

  • 25. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism.
    Green SJ, Meltzer MS, Hibbs JB, Nacy CA.
    J Immunol; 1990 Jan 01; 144(1):278-83. PubMed ID: 2104889
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of lymphokine-induced macrophage microbicidal activity against Leishmania major by liposomes: characterization of the physicochemical requirements for liposome inhibition.
    Gilbreath MJ, Hoover DL, Alving CR, Swartz GM, Meltzer MS.
    J Immunol; 1986 Sep 01; 137(5):1681-7. PubMed ID: 3745916
    [Abstract] [Full Text] [Related]

  • 27. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E, Lang T, Glaichenhaus N, Antoine JC.
    J Immunol; 1996 Jun 01; 156(11):4318-27. PubMed ID: 8666803
    [Abstract] [Full Text] [Related]

  • 28. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.
    Schafer R, Nacy CA, Eisenstein TK.
    J Immunol; 1988 Mar 01; 140(5):1638-44. PubMed ID: 3279120
    [Abstract] [Full Text] [Related]

  • 29. Susceptibility of inbred mice to Leishmania tropica infection: correlation of susceptibility with in vitro defective macrophage microbicidal activities.
    Nacy CA, Fortier AH, Pappas MG, Henry RR.
    Cell Immunol; 1983 Apr 15; 77(2):298-307. PubMed ID: 6850844
    [Abstract] [Full Text] [Related]

  • 30. Intracellular parasite kill: flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation.
    Kram D, Thäle C, Kolodziej H, Kiderlen AF.
    J Immunol Methods; 2008 Apr 20; 333(1-2):79-88. PubMed ID: 18313691
    [Abstract] [Full Text] [Related]

  • 31. Studies on intracellular killing of Leishmania major and lysis of host macrophages by immune lymphoid cells in vitro.
    Pham TV, Mauël J.
    Parasite Immunol; 1987 Nov 20; 9(6):721-36. PubMed ID: 2448731
    [Abstract] [Full Text] [Related]

  • 32. Correlation between enhanced oxidative metabolism and leishmanicidal activity in activated macrophages from healer and nonhealer mouse strains.
    Buchmüller-Rouiller Y, Mauël J.
    J Immunol; 1986 May 15; 136(10):3884-90. PubMed ID: 3009612
    [Abstract] [Full Text] [Related]

  • 33. Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. II. Analysis of cellular responses.
    James SL, Correa-Oliveira R, Leonard EJ.
    J Immunol; 1984 Sep 15; 133(3):1587-93. PubMed ID: 6431002
    [Abstract] [Full Text] [Related]

  • 34. Importance of lymphokines in the control of multiplication and dispersion of Leishmania donovani within liver macrophages of resistant and susceptible mice.
    Olivier M, Proulx C, Tanner CE.
    J Parasitol; 1989 Oct 15; 75(5):720-7. PubMed ID: 2529362
    [Abstract] [Full Text] [Related]

  • 35. Lymphokine-induced macrophage resistance to infection with Leishmania major.
    Belosevic M, Davis CE, Meltzer MS, Nacy CA.
    Adv Exp Med Biol; 1988 Oct 15; 239():239-44. PubMed ID: 3202039
    [Abstract] [Full Text] [Related]

  • 36. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
    Ruco LP, Meltzer MS.
    J Immunol; 1977 Sep 15; 119(3):889-96. PubMed ID: 330759
    [Abstract] [Full Text] [Related]

  • 37. Antileishmanial activities of macrophages from C3H/HeN and C3H/HeJ mice treated with Mycobacterium bovis strain BCG.
    Pappas MG, Nacy CA.
    Cell Immunol; 1983 Sep 15; 80(2):217-22. PubMed ID: 6349826
    [Abstract] [Full Text] [Related]

  • 38. Modulation of cyclic AMP-dependent protein kinase isozyme expression associated with activation of a macrophage cell line.
    Justement LB, Aldrich WA, Wenger GD, O'Dorisio MS, Zwilling BS.
    J Immunol; 1986 Jan 15; 136(1):270-7. PubMed ID: 2999244
    [Abstract] [Full Text] [Related]

  • 39. Suppression of macrophage antimicrobial activity by a tumor cell product.
    Szuro-Sudol A, Murray HW, Nathan CF.
    J Immunol; 1983 Jul 15; 131(1):384-7. PubMed ID: 6408180
    [Abstract] [Full Text] [Related]

  • 40. Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction.
    Sypek JP, Panosian CB, Wyler DJ.
    J Immunol; 1984 Dec 15; 133(6):3351-7. PubMed ID: 6333458
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.